Vaccine against COVID-19 or against SARS-CoV-2 infection?

被引：1

作者：

Rieske, Piotr ^{[1
,2
]}

机构：

[1] Uniwersytet Med Lodzi, Zaklad Biol Nowotwordow, Ul Zeligowskiego 7-9, PL-90752 Lodz, Poland

[2] Celther Polska, Lodz, Poland

来源：

ALERGOLOGIA POLSKA-POLISH JOURNAL OF ALLERGOLOGY | 2020年 / 7卷 / 03期

关键词：

SARS-CoV-2; vaccine; COVID-19; VIRUS; ANTIBODY; NEUTRALIZATION; MECHANISMS; RESPONSES; PARADIGM;

D O I：

10.5114/pja.2020.97913

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Article offers analysis of main aspects of SARS-CoV-2/COVID-19 vaccination (severe acute respiratory syndrome coronavirus 2/COVID-19-Coronavirus Disease 2019). Optimal vaccine should protect not only against disease COVID-19 (symptoms), but also against SARS-CoV-2 infection (spreading disease). However, this kind of vaccine - showing highest safety level is extremely difficult to get. Several additional SARS-CoV-2/COVID-19 vaccination issues were addressed in article. For example: serological passports, herd immunity, clinical trials, and role of antibodies and T cells crossreactivities. Article discusses some issues related to vaccination responsibilities.

引用

页码：131 / 145

页数：15

共 50 条

[41] Estimated COVID-19 vaccine effectiveness against seroconversion from SARS-CoV-2 Infection, March-October, 2021
Plumb, Ian D.
Fette, Lida M.
Tjaden, Ashley H.
Feldstein, Leora
Saydah, Sharon
Ahmed, Amina
Link-Gelles, Ruth
Wierzba, Thomas F.
Berry, Andrea A.
Friedman-Klabanoff, DeAnna
Larsen, Moira P.
Runyon, Michael S.
Ward, Lori M.
Santos, Roberto P.
Ward, Johnathan
Weintraub, William S.
Edelstein, Sharon
Uschner, Diane
VACCINE, 2023, 41 (15) : 2596 - 2604
[42] The Effectiveness of mRNA COVID-19 Vaccine Against SARS-CoV-2 Infection in Hemodialysis Patients: A Case-Control Study
Hamad, Abdullah I.
Elshirbeny, Mostafa
Ali, Mohamed Y.
Ghonimi, Tarek A.
Ibrahim, Rania A.
Yasin, Fadumo Y.
Singh, Poonam R.
Aly, Sahar
Abuhelaiqa, Essa
Al-Malki, Hassan A.
Alkadi, Mohamad M.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 318 - 318
[43] Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance
Lirong Cao
Jingzhi Lou
See Yeung Chan
Hong Zheng
Caiqi Liu
Shi Zhao
Qi Li
Chris Ka Pun Mok
Renee Wan Yi Chan
Marc Ka Chun Chong
William Ka Kei Wu
Zigui Chen
Eliza Lai Yi Wong
Paul Kay Sheung Chan
Benny Chung Ying Zee
Eng Kiong Yeoh
Maggie Haitian Wang
Nature Medicine, 2022, 28 : 1715 - 1722
[44] Letter to the editor: More data on vaccine efficacy/effectiveness of COVID-19 vaccines against asymptomatic SARS-CoV-2 infection
Chen, Ying-Wen
Ko, Wen-Chien
EUROSURVEILLANCE, 2021, 26 (35)
[45] SARS-CoV-2 vaccine effectiveness against infection, symptomatic and severe COVID-19: a systematic review and meta-analysis
Ssentongo, Paddy
Ssentongo, Anna E.
Voleti, Navya
Groff, Destin
Sun, Ashley
Ba, Djibril M.
Nunez, Jonathan
Parent, Leslie J.
Chinchilli, Vernon M.
Paules, Catharine, I
BMC INFECTIOUS DISEASES, 2022, 22 (01)
[46] Emerging SARS-CoV-2 Variants and Impact in Global Vaccination Programs against SARS-CoV-2/COVID-19
Gomez, Carmen Elena
Perdiguero, Beatriz
Esteban, Mariano
VACCINES, 2021, 9 (03) : 1 - 13
[47] SARS-CoV-2 Infection and COVID-19 in Children
Waghmare, Alpana
Hijano, Diego R.
CLINICS IN CHEST MEDICINE, 2023, 44 (02) : 359 - 371
[48] Epidemiology of SARS-CoV-2 infection and COVID-19
Salzberger, B.
Buder, F.
Lampl, B.
Ehrenstein, B.
Hitzenbichler, F.
Hanses, F.
INTERNIST, 2020, 61 (08): : 782 - 788
[49] Infection with SARS-CoV-2 is not the same as covid-19
Bamji, Andrew
BMJ-BRITISH MEDICAL JOURNAL, 2021, 374
[50] SARS-CoV-2 Infection and COVID-19 in Children
Waghmare, Alpana
Hijano, Diego R.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2025, 51 (01) : 139 - 156

← 1 2 3 4 5 →